-
1
-
-
34548706039
-
Transforming growth factor-β can suppress tumorigenesis through effects on the putative cancer stem or early progenitor cell and committed progeny in a breast cancer xenograft model
-
Tang B, Yoo N, Vu M, Mamura M, Nam JS, Ooshima A, Du Z, Desprez PY, Anver MR, Michalowska AM, Shih J, Parks WT and Wakefield LM: Transforming growth factor-β can suppress tumorigenesis through effects on the putative cancer stem or early progenitor cell and committed progeny in a breast cancer xenograft model. Cancer Res 67: 8643-8652, 2007.
-
(2007)
Cancer Res
, vol.67
, pp. 8643-8652
-
-
Tang, B.1
Yoo, N.2
Vu, M.3
Mamura, M.4
Nam, J.S.5
Ooshima, A.6
Du, Z.7
Desprez, P.Y.8
Anver, M.R.9
Michalowska, A.M.10
Shih, J.11
Parks, W.T.12
Wakefield, L.M.13
-
2
-
-
16844373628
-
Effect of conditional knockout of the type II TGF-β receptor gene in mammary epithelia on mammary gland development and polyomavirus middle T antigen induced tumor formation and metastasis
-
Forrester E, Chytil A, Bierie B, Aakre M, Gorska AE, Sharif-Afshar AR, Muller WJ and Moses HL: Effect of conditional knockout of the type II TGF-β receptor gene in mammary epithelia on mammary gland development and polyomavirus middle T antigen induced tumor formation and metastasis. Cancer Res 65: 2296-2302, 2005.
-
(2005)
Cancer Res
, vol.65
, pp. 2296-2302
-
-
Forrester, E.1
Chytil, A.2
Bierie, B.3
Aakre, M.4
Gorska, A.E.5
Sharif-Afshar, A.R.6
Muller, W.J.7
Moses, H.L.8
-
3
-
-
33845524970
-
Transforming growth factor-β in cancer and metastasis
-
Jakowlew SB: Transforming growth factor-β in cancer and metastasis. Cancer Metastasis Rev 25: 435-457, 2006.
-
(2006)
Cancer Metastasis Rev
, vol.25
, pp. 435-457
-
-
Jakowlew, S.B.1
-
4
-
-
33845678877
-
Role of transforming growth factor-β in cancer progression
-
Galliher AJ, Neil JR and Schiemann WP: Role of transforming growth factor-β in cancer progression. Future Oncol 2: 743-763, 2006.
-
(2006)
Future Oncol
, vol.2
, pp. 743-763
-
-
Galliher, A.J.1
Neil, J.R.2
Schiemann, W.P.3
-
5
-
-
84862495767
-
Epithelial-mesenchymal transition, the tumor microenvironment, and metastatic behavior of epithelial malignancies
-
Talbot LJ, Bhattacharya SD and Kuo PC: Epithelial-mesenchymal transition, the tumor microenvironment, and metastatic behavior of epithelial malignancies. Int J Biochem Mol Biol 3: 117-136, 2012.
-
(2012)
Int J Biochem Mol Biol
, vol.3
, pp. 117-136
-
-
Talbot, L.J.1
Bhattacharya, S.D.2
Kuo, P.C.3
-
6
-
-
44449144396
-
Epithelial-mesenchymal transition: At the crossroads of development and tumor metastasis
-
Yang J and Weinberg RA: Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis. Dev Cell 14: 818-829, 2008.
-
(2008)
Dev Cell
, vol.14
, pp. 818-829
-
-
Yang, J.1
Weinberg, R.A.2
-
7
-
-
0031944290
-
Regulation of immune responses by TGF-β
-
Letterio JJ and Roberts AB: Regulation of immune responses by TGF-β. Annu Rev Immunol 16: 137-161, 1998.
-
(1998)
Annu Rev Immunol
, vol.16
, pp. 137-161
-
-
Letterio, J.J.1
Roberts, A.B.2
-
8
-
-
34848857434
-
Transforming growth factor-beta and the immune response: Implications for anticancer therapy
-
Wrzesinski SH, Wan YY and Flavell RA: Transforming growth factor-beta and the immune response: implications for anticancer therapy. Clin Cancer Res 13: 5262-5270, 2007.
-
(2007)
Clin Cancer Res
, vol.13
, pp. 5262-5270
-
-
Wrzesinski, S.H.1
Wan, Y.Y.2
Flavell, R.A.3
-
9
-
-
0036087521
-
Lifetime exposure to a soluble TGF-β antagonist protects mice against metastasis without adverse side effects
-
Yang YA, Dukhanina O, Tang B, Mamura M, Letterio JJ, MacGregor J, Patel SC, Khozin S, Liu ZY, Green J, Anver MR, Merlino G and Wakefield LM: Lifetime exposure to a soluble TGF-β antagonist protects mice against metastasis without adverse side effects. J Clin Invest 109: 1607-1615, 2002.
-
(2002)
J Clin Invest
, vol.109
, pp. 1607-1615
-
-
Yang, Y.A.1
Dukhanina, O.2
Tang, B.3
Mamura, M.4
Letterio, J.J.5
MacGregor, J.6
Patel, S.C.7
Khozin, S.8
Liu, Z.Y.9
Green, J.10
Anver, M.R.11
Merlino, G.12
Wakefield, L.M.13
-
10
-
-
33847775958
-
Inhibition of ALK5 signaling induces physeal dysplasia in rats
-
Frazier K, Thomas R, Scicchitano M, Mirabile R, Boyce R, Zimmerman D, Grygielko E, Nold J, DeGouville AC, Huet S, Laping N and Gellibert F: Inhibition of ALK5 signaling induces physeal dysplasia in rats. Toxicol Pathol 35: 284-295, 2007.
-
(2007)
Toxicol Pathol
, vol.35
, pp. 284-295
-
-
Frazier, K.1
Thomas, R.2
Scicchitano, M.3
Mirabile, R.4
Boyce, R.5
Zimmerman, D.6
Grygielko, E.7
Nold, J.8
DeGouville, A.C.9
Huet, S.10
Laping, N.11
Gellibert, F.12
-
11
-
-
35348940144
-
Pathobiology of transforming growth factor β in cancer, fibrosis and immunologic disease, and therapeutic considerations
-
Prud'homme GJ: Pathobiology of transforming growth factor β in cancer, fibrosis and immunologic disease, and therapeutic considerations. Lab Invest 87: 1077-1091, 2007.
-
(2007)
Lab Invest
, vol.87
, pp. 1077-1091
-
-
Prud'homme, G.J.1
-
12
-
-
67449136111
-
Inhibition of transforming growth factor-β-mediated immunosuppression in tumor-draining lymph nodes augments antitumor responses by various immunologic cell types
-
Fujita T, Teramoto K, Ozaki Y, Hanaoka J, Tezuka N, Itoh Y, Asai T, Fujino S, Kontani K and Ogasawara K: Inhibition of transforming growth factor-β-mediated immunosuppression in tumor-draining lymph nodes augments antitumor responses by various immunologic cell types. Cancer Res 69: 5142-5150, 2009.
-
(2009)
Cancer Res
, vol.69
, pp. 5142-5150
-
-
Fujita, T.1
Teramoto, K.2
Ozaki, Y.3
Hanaoka, J.4
Tezuka, N.5
Itoh, Y.6
Asai, T.7
Fujino, S.8
Kontani, K.9
Ogasawara, K.10
-
14
-
-
60649089997
-
Cancer metastasis is accelerated through immunosuppression during Snail-induced EMT of cancer cells
-
Kudo-Saito C, Shirako H, Takeuchi T and Kawakami Y: Cancer metastasis is accelerated through immunosuppression during Snail-induced EMT of cancer cells. Cancer Cell 15: 195-206, 2009.
-
(2009)
Cancer Cell
, vol.15
, pp. 195-206
-
-
Kudo-Saito, C.1
Shirako, H.2
Takeuchi, T.3
Kawakami, Y.4
-
15
-
-
0028341154
-
Prominent inhibitory effects of tranilast on migration and proliferation and collagen synthesis by vascular smooth muscle cells
-
Tanaka K, Honda M, Kuramochi T and Morioka S: Prominent inhibitory effects of tranilast on migration and proliferation and collagen synthesis by vascular smooth muscle cells. Atherosclerosis 107: 179-185, 1994.
-
(1994)
Atherosclerosis
, vol.107
, pp. 179-185
-
-
Tanaka, K.1
Honda, M.2
Kuramochi, T.3
Morioka, S.4
-
16
-
-
0036288203
-
Anti-tumor effect of N-[3,4-dimethoxycinnamoyl]-anthranilic acid (tranilast) on experimental pancreatic cancer
-
Hiroi M, Onda M, Uchida E and Aimoto T: Anti-tumor effect of N-[3,4-dimethoxycinnamoyl]-anthranilic acid (tranilast) on experimental pancreatic cancer. J Nippon Med Sch 69: 224-234, 2002.
-
(2002)
J Nippon Med Sch
, vol.69
, pp. 224-234
-
-
Hiroi, M.1
Onda, M.2
Uchida, E.3
Aimoto, T.4
-
17
-
-
67650609666
-
Tranilast inhibits hormone refractory prostate cancer cell proliferation and suppresses transforming growth factor β1-associated osteoblastic changes
-
Izumi K, Mizokami A, Li YQ, Narimoto K, Sugimoto K, Kadono Y, Kitagawa Y, Konaka H, Koh E, Keller ET and Namiki M: Tranilast inhibits hormone refractory prostate cancer cell proliferation and suppresses transforming growth factor β1-associated osteoblastic changes. Prostate 69: 1222-1234, 2009.
-
(2009)
Prostate
, vol.69
, pp. 1222-1234
-
-
Izumi, K.1
Mizokami, A.2
Li, Y.Q.3
Narimoto, K.4
Sugimoto, K.5
Kadono, Y.6
Kitagawa, Y.7
Konaka, H.8
Koh, E.9
Keller, E.T.10
Namiki, M.11
-
18
-
-
77949372619
-
Tranilast inhibits cell proliferation and migration and promotes apoptosis in murine breast cancer
-
Subramaniam V, Chakrabarti R, Prud'homme GJ and Jothy S: Tranilast inhibits cell proliferation and migration and promotes apoptosis in murine breast cancer. Anticancer Drugs 21: 351-361, 2010.
-
(2010)
Anticancer Drugs
, vol.21
, pp. 351-361
-
-
Subramaniam, V.1
Chakrabarti, R.2
Prud'homme, G.J.3
Jothy, S.4
-
19
-
-
0036924727
-
Tranilast inhibits the proliferation of uterine leiomyoma cells in vitro through G1 arrest associated with the induction of p21waf1 and p53
-
Shime H, Kariya M, Orii A, Momma C, Kanamori T, Fukuhara K, Kusakari T, Tsuruta Y, Takakura K, Nikaido T and Fujii S: Tranilast inhibits the proliferation of uterine leiomyoma cells in vitro through G1 arrest associated with the induction of p21waf1 and p53. J Clin Endocrinol Metab 87: 5610-5617, 2002.
-
(2002)
J Clin Endocrinol Metab
, vol.87
, pp. 5610-5617
-
-
Shime, H.1
Kariya, M.2
Orii, A.3
Momma, C.4
Kanamori, T.5
Fukuhara, K.6
Kusakari, T.7
Tsuruta, Y.8
Takakura, K.9
Nikaido, T.10
Fujii, S.11
-
20
-
-
0035400114
-
N-[3,4-dimethoxycinnamoyl]-anthranilic acid (tranilast) inhibits transforming growth factor-β relesase and reduces migration and invasiveness of human malignant glioma cells
-
Platten M, Wild-Bode C, Wick W, Leitlein J, Dichgans J and Weller M: N-[3,4-dimethoxycinnamoyl]-anthranilic acid (tranilast) inhibits transforming growth factor-β relesase and reduces migration and invasiveness of human malignant glioma cells. Int J Cancer 93: 53-61, 2001.
-
(2001)
Int J Cancer
, vol.93
, pp. 53-61
-
-
Platten, M.1
Wild-Bode, C.2
Wick, W.3
Leitlein, J.4
Dichgans, J.5
Weller, M.6
-
21
-
-
67650305810
-
Tranilast inhibits the growth and metastasis of mammary carcinoma
-
Chakrabarti R, Subramaniam V, Abdalla S, Jothy S and Prud'homme GJ: Tranilast inhibits the growth and metastasis of mammary carcinoma. Anticancer Drugs 20: 334-345, 2009.
-
(2009)
Anticancer Drugs
, vol.20
, pp. 334-345
-
-
Chakrabarti, R.1
Subramaniam, V.2
Abdalla, S.3
Jothy, S.4
Prud'homme, G.J.5
-
22
-
-
0001824957
-
Clinical evaluation of tranilast on restenosis after percutaneous transluminal coronary angioplasty (PTCA) - A double blind placebo-controlled comparative study
-
Kato K, Tamai H, Hayakawa H, Yamaguchi T, Kanmatsuse K, Haze K, Aizawa T, Suzuki S, Takase S, Suzuki T, Nishikawa H, Nakanishi S, Kato O and Nakashima M: Clinical evaluation of tranilast on restenosis after percutaneous transluminal coronary angioplasty (PTCA) - a double blind placebo-controlled comparative study. J Clin Therapy Med 12: 65-85, 1996.
-
(1996)
J Clin Therapy Med
, vol.12
, pp. 65-85
-
-
Kato, K.1
Tamai, H.2
Hayakawa, H.3
Yamaguchi, T.4
Kanmatsuse, K.5
Haze, K.6
Aizawa, T.7
Suzuki, S.8
Takase, S.9
Suzuki, T.10
Nishikawa, H.11
Nakanishi, S.12
Kato, O.13
Nakashima, M.14
-
23
-
-
28444464515
-
Thrombospondin 1 mediates angiotensin II induction of TGF-β activation by cardiac and renal cells under both high and low glucose conditions
-
Zhou Y, Poczatek MH, Berecek KH and Murphy-Ullrich JE: Thrombospondin 1 mediates angiotensin II induction of TGF-β activation by cardiac and renal cells under both high and low glucose conditions. Biochem Biophys Res Commun 339: 633-641, 2006.
-
(2006)
Biochem Biophys Res Commun
, vol.339
, pp. 633-641
-
-
Zhou, Y.1
Poczatek, M.H.2
Berecek, K.H.3
Murphy-Ullrich, J.E.4
-
24
-
-
0035190076
-
Captopril restores transforming growth factor-β type II receptor and sensitivity to transforming growth factor-β in murine renal cell cancer cells
-
Miyajima A, Asano T and Hayakawa M: Captopril restores transforming growth factor-β type II receptor and sensitivity to transforming growth factor-β in murine renal cell cancer cells. J Urol 165: 616-620, 2001.
-
(2001)
J Urol
, vol.165
, pp. 616-620
-
-
Miyajima, A.1
Asano, T.2
Hayakawa, M.3
-
25
-
-
77952902430
-
Mechanisms of motility in metastasizing cells
-
Yilmaz M and Christofori G: Mechanisms of motility in metastasizing cells. Mol Cancer Res 8: 629-642, 2010.
-
(2010)
Mol Cancer Res
, vol.8
, pp. 629-642
-
-
Yilmaz, M.1
Christofori, G.2
-
26
-
-
75949103899
-
Integrin-TGF-β crosstalk in fibrosis, cancer and wound healing
-
Margadant C and Sonnenberg A: Integrin-TGF-β crosstalk in fibrosis, cancer and wound healing. EMBO Rep 11: 97-105, 2010.
-
(2010)
EMBO Rep
, vol.11
, pp. 97-105
-
-
Margadant, C.1
Sonnenberg, A.2
-
27
-
-
33847337912
-
Tumor evasion of the immune system by converting CD4+CD25- T cells into CD4+CD25+ T regulatory cells: Role of tumor-derived TGF-β
-
Liu VC, Wong LY, Jang T, Shah AH, Park I, Yang X, Zhang Q, Lonning S, Teicher BA and Lee C: Tumor evasion of the immune system by converting CD4+CD25- T cells into CD4+CD25+ T regulatory cells: role of tumor-derived TGF-β. J Immunol 178: 2883-2892, 2007.
-
(2007)
J Immunol
, vol.178
, pp. 2883-2892
-
-
Liu, V.C.1
Wong, L.Y.2
Jang, T.3
Shah, A.H.4
Park, I.5
Yang, X.6
Zhang, Q.7
Lonning, S.8
Teicher, B.A.9
Lee, C.10
-
28
-
-
84860828384
-
Gene silencing of TGF-β1 enhances antitumor immunity induced with a dendritic cell vaccine by reducing tumor-associated regulatory T cells
-
Conroy H, Galvin KC, Higgins SC and Mills KH: Gene silencing of TGF-β1 enhances antitumor immunity induced with a dendritic cell vaccine by reducing tumor-associated regulatory T cells. Cancer Immunol Immunother 61: 425-431, 2012.
-
(2012)
Cancer Immunol Immunother
, vol.61
, pp. 425-431
-
-
Conroy, H.1
Galvin, K.C.2
Higgins, S.C.3
Mills, K.H.4
|